Fernando Lopez-Rios

Head of Pathology and Targeted Therapies Laboratory, Hospital Universitario HM Sanchinarro, Madrid, Spain

Content by Fernando Lopez-Rios:

Diagnostics Genetics and epigenetics

On NTRK and Other Fusion Biomarkers

11/15/2019 | Fernando Lopez-Rios

Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Pathologist magazine